Areas of strength

Oncology - breast cancer, lung cancer, sarcoma

Haematology - lymphoma, leukaemia, multiple myeloma, anaemia 

Gastroenterology - viral hepatitis, NASH, hepatocellular carcinoma inflammatory bowel disease

Neurosciences - epilepsy, Parkinson's disease, MS, neurosurgery 

Cardiology - interventional devices, cardiac failure, ischaemic heart disease

Endocrinology - diabetes devices, complications, islet cell transplantation

Orthopaedics - sarcoma, limb reconstruction

Respiratory - alpha-1 anti-trypsin deficiency

Rheumatology - systemic sclerosis, SLE, arthritis

Renal disease - chronic kidney failure

Infectious diseases/ sepsis/ inflammation 

Psychiatry/mental health/addiction medicine

Additionally, we have the capacity to conduct all clinical trial phases and specific expertise with medical devices. 


Key Opinion Leaders 

Associate Professor Sue-Anne McLachlan - Director of Oncology & Cancer Services 

Associate Professor Hang Quach - Director of Clinical Haematology 

Professor Alex Thompson - Director of Gastroenterology 

Professor Michael Kamm - Gastroenterologist 

Professor Mark Cook - Director of Neurosurgery 

Professor Richard MacIsaac - Director of Endocrinology & Diabetes 

Professor David O'Neal - Endocrinology & Diabetes Research Lead 

Professor Peter Choong - Director of Orthopaedics 

Professor Kumar Visvanathan - Co-Director of Immunology Research Center 

Professor Robert Whitbourn - Director of Interventional Cardiology